Cannabidiol (CBD) “appears to be relatively safe for the treatment of obesity-induced heart disease, as it has anti-inflammatory and partially antioxidative properties”, says newly published research.
The study “explored the potential protective influence of cannabidiol (CBD) on myocardial inflammation state, with a special focus on arachidonic acid (AA), and oxidative balance in lipid overload conditions”. Research was conducted at the Medical University of Bialystok.
The 7-week experiment was conducted on male rats receiving standard or high-fat diet (HFD) with intraperitoneal CBD injections for the last 14 days. Results “revealed that CBD increased n-3 PUFAs activity in phospholipid and triacylglycerol fractions, and decreased AA content in the HFD group, especially in the phospholipid pool.”
Continue reading